Head-to-head · WeighScore
TeleDocs360 vs Trimrose
The verdict
Too close to call — both grade 55.2/100 (C).
TeleDocs360 and Trimrose land on the same WeighScore, so neither clears the other on our six graded dimensions. TeleDocs360 sits one line higher on the board (#444 vs #446) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | TeleDocs360 | Trimrose |
|---|---|---|
| WeighScore | 55.2/100 | 55.2/100 |
| Grade | C | C |
| Scorecard rank | #444 | #446 |
| Semaglutide | $399/mo (compounded) | Not disclosed |
| Tirzepatide | $399/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Graded #444 · C
Strengths
- Transparent $399/month base pricing for standard dosing
- Multiple GLP-1 options including injectable and oral semaglutide
- Cash-pay model with HSA/FSA card acceptance
- Fast online intake and 24-hour prescription approval
- Cancel anytime between shipments
Where it loses points
- Compounded-only; no FDA-approved branded options
- No published state availability list
- No individual provider credentials or board certifications shown
- Higher doses increase cost
Graded #446 · C
Strengths
- Free, no-cost, no-obligation online eligibility quiz before any commitment
- Offers a choice of a weekly compounded GLP-1 injection or a daily oral option
- Fully online — assessment, provider review, and home delivery with ongoing support
Where it loses points
- Runs on the CareValidate white-label platform and isn't the medical provider itself — a support@carevalidate.com address is exposed on the site
- Pricing isn't shown publicly; the cost and the specific compounded molecule appear only after you complete the eligibility quiz
- The states served, pharmacy partner and any LegitScript/503A certification aren't disclosed on the public site
- Markets 'up to 22.5% of body weight' — a trial figure for branded tirzepatide, not a guaranteed or compounded-specific outcome
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.